Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRA | P16234 | 5/20 | 0.43 |
| ▸ | CCNE1 | P24864 | 5/20 | 0.43 |
| ▸ | CDK2 | P24941 | 5/20 | 0.43 |
| ▸ | CTSL | P07711 | 5/20 | 0.41 |
| ▸ | TMIGD3 | P0DMS9 | 3/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7671191 | 0.89 | GBA1 (0.48) | PDGFRACCNE1CDK2CTSLTMIGD3 | |
| SCHEMBL7672318 | 0.87 | PDE1A (0.43) | PDGFRACCNE1CDK2CTSLTMIGD3 | |
| SCHEMBL7661515 | 0.87 | CCNE1 (0.54) | PDGFRACCNE1CDK2CTSLTMIGD3 | |
| SCHEMBL7672863 | 0.83 | PDGFRA (0.52) | PDGFRACCNE1CDK2TMIGD3ADORA2A | |
| SCHEMBL7674300 | 0.81 | CTSL (0.50) | PDGFRACCNE1CDK2CTSL | |
| SCHEMBL7666120 | 0.81 | PDGFRA (0.49) | PDGFRACCNE1CDK2CTSLGAA | |
| SCHEMBL7358873 | 0.80 | CTSL (0.46) | PDGFRACCNE1CDK2CTSL | |
| SCHEMBL7666365 | 0.80 | CTSL (0.41) | PDGFRACCNE1CDK2CTSLADORA2A | |
| SCHEMBL7673595 | 0.80 | KDM4E (0.45) | PDGFRACCNE1CDK2CTSL | |
| SCHEMBL7674302 | 0.79 | PDGFRA (0.44) | PDGFRACCNE1CDK2CTSLADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6414147-B1 | DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY | NEUROGEN CORPORATION | 2002-07-02 | — | — | US | claimed |
| US-6414147-B1 | DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY | NEUROGEN CORPORATION | 2002-07-02 | — | — | US | disclosed |